These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Production of Modified Autologous Conditioned Serum and Ex Vivo Assessment of Its Healing Potential in Murine Corneal Epithelium. Hsiung C; Liu YT; Su CY; Hsiung CC; Hung KH; Yeh LK J Vis Exp; 2023 Mar; (193):. PubMed ID: 37036242 [TBL] [Abstract][Full Text] [Related]
9. Effects of heat-treatment on plasma rich in growth factors-derived autologous eye drop. Anitua E; Muruzabal F; De la Fuente M; Merayo-Lloves J; Orive G Exp Eye Res; 2014 Feb; 119():27-34. PubMed ID: 24345372 [TBL] [Abstract][Full Text] [Related]
11. Beneficial Effects of Plasma Rich in Growth Factors (PRGF) Versus Autologous Serum and Topical Insulin in Ocular Surface Cells. Anitua E; de la Fuente M; Sánchez-Ávila RM; de la Sen-Corcuera B; Merayo-Lloves J; Muruzábal F Curr Eye Res; 2023 May; 48(5):456-464. PubMed ID: 36695530 [TBL] [Abstract][Full Text] [Related]
12. Effect of autologous platelet-rich plasma on persistent corneal epithelial defect after infectious keratitis. Kim KM; Shin YT; Kim HK Jpn J Ophthalmol; 2012 Nov; 56(6):544-50. PubMed ID: 22972393 [TBL] [Abstract][Full Text] [Related]
13. Autologous fibrin membrane combined with solid platelet-rich plasma in the management of perforated corneal ulcers: a pilot study. Alio JL; Rodriguez AE; Martinez LM; Rio AL JAMA Ophthalmol; 2013 Jun; 131(6):745-51. PubMed ID: 23559361 [TBL] [Abstract][Full Text] [Related]
14. Plasma Rich in Growth Factors for the Treatment of Ocular Surface Diseases. Anitua E; Muruzabal F; de la Fuente M; Merayo J; Durán J; Orive G Curr Eye Res; 2016 Jul; 41(7):875-82. PubMed ID: 26828610 [TBL] [Abstract][Full Text] [Related]
15. Effect of platelet-rich plasma in nerve regeneration after LASIK. Javaloy J; Alió JL; Rodriguez AE; Vega A; Muñoz G J Refract Surg; 2013 Mar; 29(3):213-9. PubMed ID: 23446019 [TBL] [Abstract][Full Text] [Related]
16. Platelet-rich plasma: a milieu of bioactive factors. Boswell SG; Cole BJ; Sundman EA; Karas V; Fortier LA Arthroscopy; 2012 Mar; 28(3):429-39. PubMed ID: 22284405 [TBL] [Abstract][Full Text] [Related]
17. Platelet-rich plasma as treatment for persistent ocular epithelial defects. Ronci C; Ferraro AS; Lanti A; Missiroli F; Sinopoli S; Del Proposto G; Cipriani C; De Felici C; Ricci F; Ciotti M; Cudillo L; Arcese W; Adorno G Transfus Apher Sci; 2015 Jun; 52(3):300-4. PubMed ID: 25728718 [TBL] [Abstract][Full Text] [Related]
18. The basic science of platelet-rich plasma (PRP): what clinicians need to know. Arnoczky SP; Sheibani-Rad S Sports Med Arthrosc Rev; 2013 Dec; 21(4):180-5. PubMed ID: 24212364 [TBL] [Abstract][Full Text] [Related]
19. The Use of Platelet-Rich and Platelet-Poor Plasma to Enhance Differentiation of Skeletal Myoblasts: Implications for the Use of Autologous Blood Products for Muscle Regeneration. Miroshnychenko O; Chang WT; Dragoo JL Am J Sports Med; 2017 Mar; 45(4):945-953. PubMed ID: 28027451 [TBL] [Abstract][Full Text] [Related]
20. [Effects of human adipose-derived mesenchymal stem cells and platelet-rich plasma on healing of wounds with full-thickness skin defects in mice]. Lei XX; Xu PC; Zhang L; Pang MR; Tian J; Cheng B Zhonghua Shao Shang Za Zhi; 2018 Dec; 34(12):887-894. PubMed ID: 30585053 [No Abstract] [Full Text] [Related] [Next] [New Search]